XNYS
PHR
Market cap658mUSD
Jul 09, Last price
10.82USD
1D
1.50%
1Q
34.24%
IPO
-54.92%
Name
Phreesia Inc
Chart & Performance
P/E
290.03
P/S
1.39
EPS
0.04
Div Yield, %
—
Shrs. gr., 5y
9.25%
Rev. gr., 5y
26.45%
Revenues
481m
+14.48%
Net income
2m
P
CFO
79m
+143.40%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Phreesia, Inc. delivers a comprehensive, integrated software-as-a-service (SaaS) and payment processing platform, specifically designed for the healthcare sector across the United States and Canada. At its core, the Phreesia Platform offers a full spectrum of tools to streamline the patient intake journey, alongside a seamlessly integrated payment system for handling patient financial transactions. The platform is accessible through various channels, including Phreesia Mobile for use on patients' personal mobile devices, Phreesia Dashboard (a web interface for healthcare providers), self-service PhreesiaPads tablets, and on-site Arrivals Kiosks. Beyond intake and payments, the Phreesia Platform extends its capabilities with a registration module for automated patient self-registration, and a revenue cycle management suite encompassing insurance verification, point-of-sale payment applications, and cost estimation. Furthermore, access solutions facilitate online appointment scheduling, reminders, and referral tracking, while a dedicated life sciences solution enables the delivery of targeted and clinically appropriate marketing content to patients. The platform also incorporates a clinical support solution designed to gather clinical intake and patient-reported outcome (PRO) data across roughly 25 medical specialties. This solution also empowers healthcare providers to engage with patients via surveys, announcements, text/email messages, and health campaigns. Additionally, specialized COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for self-reported risk factors, facilitating contactless in-person check-ins, and collecting necessary intake information for telehealth consultations. Phreesia caters to a diverse clientele, including individual patients, various healthcare organizations (from single-specialty practices to multi-specialty groups and large health systems), and companies within the pharmaceutical, medical device, and biotechnology sectors. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2026‑01 | 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||